StartUps
– The new brain module, utilizes a small, frameless platform with only three points of fixation, will launch and demo at American Association of Neurological Surgeons...
Hi, what are you looking for?
– The new brain module, utilizes a small, frameless platform with only three points of fixation, will launch and demo at American Association of Neurological Surgeons...
– Synthon says its Phase III clinical trial of glatiramer acetate found an equivalent efficacy and safety profile to Copaxone. – – Dutch drug...
– – Mazor Robotics, Ltd. (TASE: MZOR; NASDAQ GM: MZOR), announced that for the first time ever, a surgeon utilized Mazor Robotics Renaissance Guidance System...
– Tel Aviv University researcher uses DNA therapy in lab mice to improve cochlear implant functionality. – – One in a thousand children in...
– According to IMS data Xeloda made by Genentech, had $754 million in US sales in 2013. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA)...
– The foundation, established by billionaire businessman and philanthropist Alfred E. Mann, has formed the company to produce and market an infusion pump designed...
– Teva has 180 days of marketing exclusivity for generic Evista, which had 2013 US sales of $824 million. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)...
– Berg has devoted considerable time, energy as well as capital in his latest venture, Berg Pharma in the search for new treatments for...
– The first and only orally inhaled medicine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults. –...
– Brainsway has leased a Deep TMS system to Harvard University’s McLean Hospital. – – Brainsway Ltd. (TASE:BRIN) has leased a Deep TMS (transcranial magnetic...